Top Markets
Coin of the day
BioNxt Solutions Inc. BioNxt Solutions Inc.

BioNxt Solutions Inc.

BNXT
Kedudukan dalam Saham #27435
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017,... Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
Harga Saham
$0.25320823
Disegerakkan terakhir: 2026-08-19
Modal Pasaran
$32.92M
Perubahan (1 hari)
2.99%
Perubahan (1 tahun)
-65.56%
Negara
CA
Perdagangan BioNxt Solutions Inc. (BNXT)

Kategori

Nisbah P/S bagi BioNxt Solutions Inc. (BNXT)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini BioNxt Solutions Inc., nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk BioNxt Solutions Inc. dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa